Answers are grounded in this paper and cite their sources.
The National guidelines "2022 Prevention of chronic non-communicable diseases in the Russian Federation" in the subsection "Pharmacotherapy of tobacco dependence" contain insufficiently correct statements about contraindications for use, efficacy and tolerability of cytisine. This paper presents a detailed analysis of these statements.
No takes yet. Share an insight, caveat, or question.
Bel'diev et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: